EUCTR2004-000148-26-CZ进行中（未招募）不适用
A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term treatment of rotigotine patch in subjects with advanced stage, idiopathic Parkinson's disease who are not well controlled on levodopa - N/A
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Subject is informed and given ample time and opportunity to think about his/her
- •participation in this trial and has given his/her written informed consent
- •- Subject is willing and able to comply with all trial requirements
- •- Subject has completed 4 months of maintenance treatment in the double-blind trial
- •Are the trial subjects under 18?
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Subject has an ongoing serious adverse event in trial SP515 that is assessed as
- •related to study medication
研究者
相似试验
进行中（未招募）
不适用
A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term treatment of rotigotine patch in subjects with advanced stage, idiopathic Parkinson's disease who are not well controlled on levodopa - N/AParkinson's DiseaseEUCTR2004-000148-26-FISchwarz BioSciences Inc.360
进行中（未招募）
1 期
A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term treatment of rotigotine patch in subjects with advanced stage, idiopathic Parkinson's disease who are not well controlled on levodopa - N/AParkinson's DiseaseEUCTR2004-000148-26-ESSchwarz BioSciences Inc.360
进行中（未招募）
不适用
A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term treatment of rotigotine patch in subjects with advanced stage, idiopathic Parkinson's disease who are not well controlled on levodopa - N/AParkinson's DiseaseEUCTR2004-000148-26-SESchwarz BioSciences Inc.360
进行中（未招募）
不适用
A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term treatment of rotigotine patch in subjects with advanced stage, idiopathic Parkinson's disease who are not well controlled on levodopa - N/AParkinson's DiseaseEUCTR2004-000148-26-ATSchwarz BioSciences Inc.360
进行中（未招募）
不适用
A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term treatment of rotigotine patch in subjects with advanced stage, idiopathic Parkinson's disease who are not well controlled on levodopa - N/AParkinson's DiseaseEUCTR2004-000148-26-HUSchwarz BioSciences Inc.360